USP17L2 and non-small cell lung carcinoma: In addition, our group and others have shown that USP17 is overexpressed in a range of tumors when compared to normal tissue (Non-small cell lung cancer (NSCLC), ovarian, breast, colon, esophagus, cervical, osteosarcoma) [9–14].